Home/Filings/4/0001437749-25-000452
4//SEC Filing

Gruber James R. 4

Accession 0001437749-25-000452

CIK 0001710340other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:15 PM ET

Size

7.6 KB

Accession

0001437749-25-000452

Insider Transaction Report

Form 4
Period: 2025-01-03
Gruber James R.
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2025-01-03+25,87625,876 total
    Common Stock (25,876 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2025-01-03+38,62138,621 total
    Exercise: $13.00Exp: 2035-01-02Common Stock (38,621 underlying)
Footnotes (3)
  • [F1]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
  • [F3]The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.

Issuer

Eton Pharmaceuticals, Inc.

CIK 0001710340

Entity typeother

Related Parties

1
  • filerCIK 0001923165

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:15 PM ET
Size
7.6 KB